← Back
$EVH All transactions

Evolent Health, Inc.

F

$ Value

$15K

Shares

4,311

Price

$4

Filed

Mar 4

Insider

Name

Shams Aammaad

Title

Chief Accounting Officer

CIK

0001815354

Roles

Officer

Transaction Details

Transaction Date

2026-03-03

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

66,847

Footnotes

This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. | Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. | Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2024, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 2, 2026. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2025. | This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units. | Represents performance-based share units (PSUs) granted to Mr. Shams pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.

Filing Info

Accession No.

0001628908-26-000019

Form Type

4

Issuer CIK

0001628908

Shams Aammaad's History

Date Ticker Type Value
2026-03-03 EVH F $15K
2026-03-02 EVH A $0
2026-03-02 EVH F $3K
2026-03-02 EVH A $0
2026-03-01 EVH F $8K
2025-08-01 EVH F $26K

Other Insiders at EVH (90d)

Insider Bought Sold Last
Weinberg Jonathan
General Counsel
2026-03-03
Blackley Seth
Chief Executive Officer
2026-03-03
Shams Aammaad
Chief Accounting Officer
2026-03-02
Ramos Mario
Chief Financial Officer
2026-03-02
McCarthy Daniel Joseph
PRESIDENT
2026-03-03